Access to anti-retroviral drugs, male in Euro area
Euro area: Access to anti-retroviral drugs, male was 87.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, male in Euro area, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Euro area is 87.0%, measured in 2022. That is the highest value across all 23 years on record.
The figure is up 1.2% on the previous year and up 26.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Euro area peaked at 87.0% in 2022 and was at its lowest, 38.3%, in 2000.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, male in Euro area, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 38.3% | — |
| 2001 | 41.6% | +8.6% |
| 2002 | 44.6% | +7.0% |
| 2003 | 47.3% | +6.1% |
| 2004 | 50.0% | +5.8% |
| 2005 | 52.1% | +4.3% |
| 2006 | 54.4% | +4.4% |
| 2007 | 56.9% | +4.5% |
| 2008 | 59.5% | +4.6% |
| 2009 | 62.0% | +4.3% |
| 2010 | 65.2% | +5.1% |
| 2011 | 67.1% | +2.8% |
| 2012 | 69.0% | +2.8% |
| 2013 | 71.4% | +3.5% |
| 2014 | 73.7% | +3.2% |
| 2015 | 76.1% | +3.3% |
| 2016 | 79.5% | +4.4% |
| 2017 | 81.9% | +3.0% |
| 2018 | 83.5% | +2.0% |
| 2019 | 85.2% | +2.1% |
| 2020 | 85.3% | +0.1% |
| 2021 | 85.9% | +0.7% |
| 2022 | 87.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.7% | 38.3% | 62.0% | 10 |
| 2010s | 75.2% | 65.2% | 85.2% | 10 |
| 2020s | 86.1% | 85.3% | 87.0% | 3 |
Countries ranked near Euro area
More gender data for Euro area
- Labor force, female 81.83 million (2025)
- Labor force, female, per capita 0.2281 units per person (2025)
- Labor force, female, per unit of GDP 0 units per US$ of GDP (2025)
- Labor force, female, annual growth rate -0.0473 % change on previous year (2025)
- Labor force, female, per square kilometre 28.76 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.0959 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.1756 per 1,000 uninfected male population ages 15-49 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 97.9% (2025)
- School life expectancy, primary to tertiary, female 17.23 years (2019)
- School life expectancy, primary to tertiary, male 16.65 years (2019)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Euro area?
- Access to anti-retroviral drugs, male in Euro area was 87.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Euro area?
- The highest recorded value was 87.0% in 2022.
- What is the lowest access to anti-retroviral drugs, male recorded in Euro area?
- The lowest recorded value was 38.3% in 2000.
- How does Euro area rank for access to anti-retroviral drugs, male?
- Euro area ranks 1st out of 19 groups with data for 2022.
- Is access to anti-retroviral drugs, male rising or falling in Euro area?
- Over the last ten years it is up 26.1%. The long-run trend across the full record is rising.
- Where does this Euro area data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.